id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-1696-0052,FDA,FDA-2014-D-1696,"Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products; Draft Guidance for Industry and Food and Drug Administration Staff; Reopening of the Comment Period",Proposed Rule,Reopening of Comment Period,2015-10-30T04:00:00Z,2015,10,2015-10-30T04:00:00Z,2016-04-30T03:59:59Z,2024-11-12T05:48:38Z,2015-27705,1,0,0900006481cfca64
FDA-2014-D-1696-0048,FDA,FDA-2014-D-1696,Request to Extend Comment Period from Association of Organ Procurement Organizations,Other,Request for Extension,2015-02-27T05:00:00Z,2015,2,2015-02-27T05:00:00Z,,2015-02-27T20:31:58Z,,0,0,0900006481a1f1cf